Biohybrid systems allow for new applications in food technology, molecular biology, medical diagnostics, and pharmaceutical industry
Cells, biological circuits, and individual biomolecules organize themselves and interact with the environment. Use of these capabilities in flexible and economically efficient biotechnological production systems is in the focus of the “Molecular Interaction Engineering” (MIE) project. It is the objective to develop printed biological circuits and catalysts for biologico-technical hybrid systems. MIE will be funded with about EUR 3.5 million by the BMBF.
The capabilities of biological systems are based on specific interactions of molecular components. Due to their molecular fitting accuracy, for instance, enzymes allow for certain chemical reactions only. Some proteins bind via specific molecular interfaces to the DNA or other proteins and control processes in complex organisms. Sensors respond to defined molecular signals from the environment. The MIE project focuses on interactions of molecules, technical interfaces, and surrounding solvents.
“Transfer of complex biological mechanisms to printable systems may result in innovative biotechnologies that might be the basis of a number of industrial applications,” Professor Jürgen Hubbuch, project coordinator at KIT, explains. However, conventional, continuous evolution of biological molecules reaches its limits. The key to innovative developments is the specific, adjusted construction of the interaction of complex biomolecules and fusion of these units with technical interfaces. This requires close cooperation of biology, engineering, chemistry, and physics.
The “Molecular Interaction Engineering” (MIE) project combines methods of biotechnology, structural biology, materials sciences, process engineering, and computer simulation. Work is aimed at developing innovative, flexible, and economically efficient biotechnological production systems for molecules. These might then be used in biohybrid systems integrating biological and electronic components. Biohybrid systems allow for new applications in food technology, molecular biology, medical diagnostics, and pharmaceutical industry.
The Latest on: Printable Biotechnology
- For biotech industry, a milestone: Vertex names woman as president, CEOon July 26, 2019 at 7:48 am
Score one for gender diversity in the male-dominated biotech industry. Vertex Pharmaceuticals said Thursday that its chief medical officer, Reshma Kewalramani, will take over as president and chief ... […]
- Need a bone? Israeli company is growing them in a labon July 25, 2019 at 10:07 am
Bones can also be held together by bone substitutes, including metal pins, screws and bars. Haifa-based biotechnology company Bonus BioGroup, however, has developed a unique technology that promises ... […]
- Biotechnology Companies Step up to Better Combat Global Outbreakson July 25, 2019 at 6:31 am
Nevertheless, biotechnology companies have aimed to develop innovative ... quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full ... […]
- Developer, biotech investment firm plan eight-story South Boston labon July 16, 2019 at 5:09 am
A heavyweight New York developer and a deep-pocketed biotech investment firm are teaming up to build a big lab building on First Street in South Boston, the latest sign that this once-gritty section ... […]
- Czech PPF Group biotech firms begin trials to extend lives of cancer patientson July 11, 2019 at 5:12 am
Biotech companies within the PPF Group, controlled by Czech billionaire Petr Kellner, are reporting advances in efforts to extend the lives of cancer patients. The companies Sotio and Cytune Pharma ... […]
via Google News and Bing News